Loading...

Loading...

Moderna to Issue US$2 Billion Convertible Notes for Oncology Push
By Sergio Arturo Lievano Madrigal - Thu, 08/27/2026 - 13:54
Moderna aims to raise US$2 billion in convertible notes to fund oncology growth and debt repayment, following a rally driven by melanoma vaccine data.
https://mexicobusiness.news/tag/oncology
More Health
This Week in Health: Hospitals, AI Adherence, and Pharma Reform
By Sergio Arturo Lievano Madrigal - Thu, 08/20/2026 - 15:14
This week: ISSSTE opens a new Tampico hospital, AI reshapes patient adherence and mental health, and Mexico debates its health insurance reform.
Merck, Moderna Report Positive Results for Their Melanoma Vaccine
By Sergio Arturo Lievano Madrigal - Wed, 08/19/2026 - 12:04
Merck and Moderna's mRNA melanoma vaccine clears Phase 3, as Mexico speeds trial approvals to attract advanced oncology research investment.
Driving Clinical Research While Enhancing Patient Experience
By Sergio Arturo Lievano Madrigal - Thu, 08/13/2026 - 14:46
Complex disease burdens should be addressed by considering the entire patient journey rather than isolated interventions, says AbbVie’s Sergio Vargas.
The Week in Health: Pharma Mega-Merger Talks, Hospital Push
By Sergio Arturo Lievano Madrigal - Thu, 08/06/2026 - 16:33
AstraZeneca-Bristol Myers merger talks, Oaxaca's new hospital complex, and an accelerating Ebola outbreak headline this week's health news.
Placing Patients, Society at the Heart of Every Decision
By Sergio Arturo Lievano Madrigal - Thu, 08/06/2026 - 08:43
Early diagnosis is a critical bottleneck that can be addressed through medical education and awareness campaigns, says Eisai México’s Rafael Dávila.
Cancer: Comprehensive Care and Support, Not Just Technology
By Alejandro Torres Martinez - Thu, 08/06/2026 - 07:00
Leveraging adaptive radiotherapy, AI, and comprehensive support transforms personalized cancer care, writes Alejandro Torres.
AstraZeneca, Bristol Myers Squibb Explore US$400 Billion Merger
By Sergio Arturo Lievano Madrigal - Mon, 08/03/2026 - 11:48
AstraZeneca and Bristol Myers Squibb hold merger talks for a possible US$400 billion deal, say sources.
TAPI Mexico Invests MX$140M in Oncology API Production
By Sergio Arturo Lievano Madrigal - Fri, 07/31/2026 - 11:50
TAPI Mexico invests MX$140 million to expand its API plant in Lerma, boosting national oncology drug production and earning Hecho en Mexico status.
Global Growth Fuels Boehringer Ingelheim's Mexico Bet
By Sergio Arturo Lievano Madrigal - Thu, 07/30/2026 - 12:56
Boehringer Ingelheim's 16.2% 1H26 sales growth coincides with a 22% rise in its Mexico clinical research investment for the year.
IMSS Authorizes Two New Specialized Hospitals
By Sergio Arturo Lievano Madrigal - Fri, 06/19/2026 - 15:03
IMSS approved two new hospitals in Ecatepec and Guaymas, highlighting Mexico’s focus on specialized care, diagnostic speed and healthcare capacity.